[HTML][HTML] Defining risk groups to yellow fever vaccine-associated viscerotropic disease in the absence of denominator data

SJ Seligman, JE Cohen, Y Itan… - The American Journal …, 2014 - ncbi.nlm.nih.gov
The American Journal of Tropical Medicine and Hygiene, 2014ncbi.nlm.nih.gov
Several risk groups are known for the rare but serious, frequently fatal, viscerotropic
reactions following live yellow fever virus vaccine (YEL-AVD). Establishing additional risk
groups is hampered by ignorance of the numbers of vaccinees in factor-specific risk groups
thus preventing their use as denominators in odds ratios (ORs). Here, we use an equation to
calculate ORs using the prevalence of the factor-specific risk group in the population who
remain well. The 95% confidence limits and P values can also be calculated. Moreover, if …
Abstract
Several risk groups are known for the rare but serious, frequently fatal, viscerotropic reactions following live yellow fever virus vaccine (YEL-AVD). Establishing additional risk groups is hampered by ignorance of the numbers of vaccinees in factor-specific risk groups thus preventing their use as denominators in odds ratios (ORs). Here, we use an equation to calculate ORs using the prevalence of the factor-specific risk group in the population who remain well. The 95% confidence limits and P values can also be calculated. Moreover, if the estimate of the prevalence is imprecise, discrimination analysis can indicate the prevalence at which the confidence interval results in an OR of∼ 1 revealing if the prevalence might be higher without yielding a non-significant result. These methods confirm some potential risk groups for YEL-AVD and cast doubt on another. They should prove useful in situations in which factor-specific risk group denominator data are not available.
ncbi.nlm.nih.gov